Allogeneic Stem-Cell Transplantation As Salvage Therapy for Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma Relapsing After an Autologous Stem-Cell Transplantation: An Analysis of the European Group for Blood and Marrow Transplantation Registry
Roel J.W. van Kampen(Zuyderland Medisch Centrum), Anna Sureda(Institut d'Investigació Biomédica de Bellvitge), Sébastien Maury(Assistance Publique – Hôpitaux de Paris), Nöel Milpied(Hôpital Cardiologique du Haut-Lévêque), Harry C. Schouten, Arnon Nagler(Sheba Medical Center), Carmen Canals(Hospital de Sant Pau), Agnès Buzyn(Hôpital Saint-Jacques), Kirsty Thomson(University College Hospital), Gert J. Ossenkoppele(Dutch Cancer Society), Jean‐Pierre Jouet(Hôpital Claude Huriez), Jean-Paul Vernant(Hôpital Edouard Herriot), Marc Boogaerts(Universitair Ziekenhuis Leuven), J.J. Luan(Hôpital Claude Huriez)
Cited by 216
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3.1k
KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma
|New England Journal of Medicine|2020|1.9k